RecruitingNCT05507125

Regulation of Inflammatory Genes in Hidradenitis Suppurativa


Sponsor

University of Alabama at Birmingham

Enrollment

200 participants

Start Date

Oct 11, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria2

  • Diagnosed with hidradenitis suppurativa
  • Not Pregnant

Exclusion Criteria3

  • Mild/general dermatological issues like moles, other cosmetic issues
  • Patients with hidradenitis suppurativa, psoriasis, roasacea, atopic dermatitis and other inflammatory skin disease
  • Pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMental health

Early life exposure to abuse and development of hidradenitis suppurativa


Locations(1)

Whitaker Clinic

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05507125


Related Trials